Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.800
-0.170 (-4.28%)
At close: May 11, 2026, 4:00 PM EDT
3.700
-0.100 (-2.63%)
After-hours: May 11, 2026, 6:27 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $187.83 million as of May 11, 2026. Its market cap has increased by 165.88% in one year.
Market Cap
187.83M
Enterprise Value
59.84M
1-Year Change
165.88%
Ranking
Category
Stock Price
$3.80
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $187.83M, a decrease of -65.27%. That is a compound annual growth rate of -20.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 196.23M | 72.06% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 202.78M |
| Tiziana Life Sciences | 201.65M |
| Unicycive Therapeutics | 200.39M |
| Tonix Pharmaceuticals Holding | 200.15M |
| Precision BioSciences | 198.43M |
| Karyopharm Therapeutics | 194.77M |
| Corbus Pharmaceuticals Holdings | 194.39M |
| MacroGenics | 190.68M |